GSK wins FDA nod for new shingles vaccine format

4 hours ago 1
GSK -Glaxosmithkline headquarters office building in Poznan.

Magdalena Wygralak

GSK (NYSE:GSK) announced Thursday that the U.S. Food and Drug Administration (FDA) approved a new prefilled syringe presentation of its shingles vaccine, Shingrix, offering a convenient administration option for healthcare workers.

The current version of the vaccine comprises two vials—one

Recommended For You

More Trending News

Read Entire Article